Cargando…

Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent

Detalles Bibliográficos
Autores principales:	Huseynov, Aydin, Behnes, Michael, Ansari, Uzair, Baumann, Stefan, Lossnitzer, Dirk, El-Battrawy, Ibrahim, Fastner, Christian, Borggrefe, Martin, Akin, Ibrahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2019
Materias:	Letter To The Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911800/ https://www.ncbi.nlm.nih.gov/pubmed/31853250 http://dx.doi.org/10.11909/j.issn.1671-5411.2019.11.001

Ejemplares similares

Clinical outcomes associated with catecholamine use in patients diagnosed with Takotsubo cardiomyopathy
por: Ansari, Uzair, et al.
Publicado: (2018)

Follow-up of iatrogenic aorto-coronary "Dunning" dissections by cardiac computed tomography imaging
por: Baumann, Stefan, et al.
Publicado: (2017)

Takotsubo syndrome and cardiac implantable electronic device therapy
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Is Extended Duration of Dual Antiplatelet Therapy After Carotid Stenting Beneficial?
por: Jhang, Kai-Ming, et al.
Publicado: (2015)

Age related differences and outcome of patients with Takotsubo syndrome
por: Huseynov, Aydin, et al.
Publicado: (2017)

Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice
por: Cho, Min Soo, et al.
Publicado: (2017)

Incidence and Prognostic Relevance of Cardiopulmonary Failure in Takotsubo Cardiomyopathy
por: El-Battrawy, Ibrahim, et al.
Publicado: (2017)

Short‐term and long‐term incidence of stroke in Takotsubo syndrome
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2018)

Short- and Long-Term Incidence of Thromboembolic Events in Takotsubo Syndrome as Compared With Acute Coronary Syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
por: Shen, Ying, et al.
Publicado: (2015)

Is the Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents the Longer the Better?
por: Huang, Qing-Yu, et al.
Publicado: (2015)

Impact of ST-segment elevation on the outcome of Takotsubo syndrome
por: Gietzen, Thorsten, et al.
Publicado: (2019)

Duration of dual antiplatelet therapy in acute coronary syndrome
por: Wilson, Simon John, et al.
Publicado: (2017)

The Use of Beta Blockers in Takotsubo Syndrome as Compared to Acute Coronary Syndrome
por: Kummer, Marvin, et al.
Publicado: (2020)

Galectin-3 Reflects the Echocardiographic Grades of Left Ventricular Diastolic Dysfunction
por: Ansari, Uzair, et al.
Publicado: (2018)

Optimal Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: Shorter or Longer?
por: Chang, Mineok, et al.
Publicado: (2014)

Association of a congenital long QT syndrome type 1 with Takotsubo cardiomyopathy
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2016)

Left atrial appendage morphology, echocardiographic characterization, procedural data and in-hospital outcome of patients receiving left atrial appendage occlusion device implantation: a prospective observational study
por: Fastner, Christian, et al.
Publicado: (2016)

Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular function
por: Becher, Tobias, et al.
Publicado: (2018)

Optimal duration of dual antiplatelet therapy for coronary artery disease
por: Kikkert, W. J., et al.
Publicado: (2018)

Final five‐year results of the REMEDEE Registry: Real‐world experience with the dual‐therapy COMBO stent
por: Kerkmeijer, Laura S.M., et al.
Publicado: (2020)

Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review
por: Carciotto, Gabriele, et al.
Publicado: (2023)

Clinical and echocardiographic analysis of patients suffering from recurrent takotsubo cardiomyopathy
por: El-Battrawy, Ibrahim, et al.
Publicado: (2016)

Optimal duration of dual antiplatelet therapy after drug eluting stent implantation: a network meta-analysis
por: Gajulapalli, Rama Dilip, et al.
Publicado: (2017)

Influence of dual antiplatelet therapy duration on neointimal condition after second-generation drug-eluting stent implantation
por: Goryo, Yutaka, et al.
Publicado: (2021)

Duration of Dual Antiplatelet Therapy After Implantation of Drug-Coated Balloon
por: Zhang, Yuxuan, et al.
Publicado: (2021)

Design and Rationale of the Femoral Closure versus Radial Compression Devices Related to Percutaneous Coronary Interventions (FERARI) Study
por: Behnes, Michael, et al.
Publicado: (2015)

Dual antiplatelet therapy and drug eluting stents: a marriage of convenience
por: Benezet-Mazuecos, Juan, et al.
Publicado: (2007)

- LAA Occluder View for post-implantation Evaluation (LOVE) - standardized imaging proposal evaluating implanted left atrial appendage occlusion devices by cardiac computed tomography
por: Behnes, Michael, et al.
Publicado: (2016)

Duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of large randomised controlled trials
por: Tsoi, Man-Fung, et al.
Publicado: (2015)

Duration of Dual Antiplatelet Therapy After Stent Implantation, Still an Enigma: A Systematic Review of Randomized Clinical Trials
por: Aslam Zahid, Muhammad Bin, et al.
Publicado: (2021)

Role of insulin-like growth factor 1 in stent thrombosis under effective dual antiplatelet therapy
por: Yalcin, Ahmet Arif, et al.
Publicado: (2014)

International patterns of dual antiplatelet therapy duration after acute coronary syndromes
por: Bueno, Héctor, et al.
Publicado: (2017)

Corrigendum: Comparison and Outcome Analysis of Patients with Takotsubo Cardiomyopathy Triggered by Emotional Stress or Physical Stress
por: Giannakopoulos, Konstantinos, et al.
Publicado: (2017)

Comparison and Outcome Analysis of Patients with Takotsubo Cardiomyopathy Triggered by Emotional Stress or Physical Stress
por: Giannakopoulos, Konstantinos, et al.
Publicado: (2017)

Statin therapy is associated with improved survival in patients with ventricular tachyarrhythmias
por: Rusnak, Jonas, et al.
Publicado: (2019)

Short versus long duration of dual antiplatelet therapy following drug-eluting stents: a meta-analysis of randomised trials
por: Rozemeijer, R., et al.
Publicado: (2018)

Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis
por: Yin, Shang-He-Lin, et al.
Publicado: (2019)

Duration of dual antiplatelet therapy in patients with acute coronary syndrome undergoing drug-eluting stent implantation: A meta-analysis
por: Geng, Xue, et al.
Publicado: (2020)

Prevalence, Clinical Characteristics, and Predictors of Patients with Thromboembolic Events in Takotsubo Cardiomyopathy
por: El-Battrawy, Ibrahim, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oeqmgdv8mfdruhic6rpk7p1vd9